Quality of life in patients receiving opioid maintenance therapy: A comparative study of slow-release morphine versus methadone treatment

European Addiction Research

Volumn 14, Issue 2, 2008, Pages 99-105

  Winklbaur, Bernadette ^a   Jagsch, Reinhold ^b   Ebner, Nina ^a   Thau, Kenneth ^a   Fischer, Gabriele ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Methadone; Morphine; Opioid addiction; Quality of life

Indexed keywords

METHADONE; MORPHINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE TITRATION; FEMALE; HEALTH STATUS; HUMAN; LEISURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NARCOTIC DEPENDENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SLOW RELEASE FORMULATION;

ADULT; ANALGESICS, OPIOID; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; MORPHINE; OPIOID-RELATED DISORDERS; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 40549097470     PISSN: 10226877     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113724     Document Type: Article

References (46)

1. Wiklund I: Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life . Fund Clin Pharmacol 2004;18:351-363.
2. Stein MD, Mulvey KP, Plough A, Smith JH: The functioning and well-being of persons who seek treatment for drug and alcohol use. J Subst Abuse 1998;10:75-84.
3. Fleischhacker W, Rabinowitz J, Kemmler G, Eerdekens M, Mehnert A: Perceived functioning, well-being and psychiatric symptoms in patients with stable schizophrenia treated with long-acting risperidone for 1 year. Br J Psychiatry 2005;187:131-136.
4. Evans S, Huxley P, Priebe S: A comparison of quality of life of severely mentally ill people in UK and German samples. Int J Soc Psychiatry 2000;46:47-56.
5. Jagsch R, Pils K: Which instrument is more suitable to assess health-related quality of life: Nottingham Health Profile of Short-Form-36? Wien Med Wochenschr 2006;156:149-157.
6. Bullinger M: Methodological basis and aspects of quality of life. Dtsch Med Wochenschr 2006;131:S5-S7.
7. Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J, Osher FC: Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care 2000;38:1141-1150.
8. Arpinelli F, Bamfi F: The FDA guidance for industry on PROs: the point of view of a pharmaceutical company. Health Qual Life Outcomes 2006;4:85.
9. Patrick DL, Erickson P: Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York, Oxford University Press, 1993.
10. Dimenas ES, Dahlof CG, Jern SC, Wiklund IK: Defining quality of life in medicine. Scan J Prim Health Care 1990;1:7-10.
11. Vanagas G, Padaiga Z, Subata E: Drug addiction maintenance treatment and quality of life measurements. Medicina (Kaunas) 2004;40:833-841.
12. Ritsner M, Modai I, Endicott J, Rivkin O, Nechamkin Y, Barak P, Golding V, Ponizovsky A: Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 2000;61:880-889.
13. Lochner C, Mogotsi M, du Toit PL, Kaminer D, Niehaus DJ, Stein DJ: Quality of life in anxiety disorders: a comparison of obsessive-compulsive disorder, social anxiety disorder, and panic disorder. Psychopathology 2003;36:255-262.
14. Smith KW, Larson MJ: Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. Am J Drug Alcohol Abuse 2003;29:323-335.
15. Giacomuzzi SM, Riemer Y, Ertl M, Kemmler G, Rössler H, Hinterhuber H, Kurz M: Gender differences in health-related quality of life in admission to a maintenance treatment program. Eur Addict Res 2005;11:69-75.
16. Puigdollers E, Domingo-Salvany A, Brugal MT, Torrens M, Alvaros J, Castillo C, Magri N, Martin S, Vazquez JM: Characteristics of heroin addicts entering methadone maintenance treatment: quality of life and gender. Subst Use Misuse 2004;39:1353-1368.
17. Fassino S, Abbate Daga G, Delsedime N, Rogna L, Boggio S: Quality of life and personality disorders in heroin abusers. Drug Alcohol Depend 2004;76:73-80.
18. Bizzarri J, Rucci P, Vallotta A, Girelli M, Sandolari A, Zerbetto E, Sbrana A, Iagher C, Dellantonio E: Dual diagnosis and quality of life in patients in treatment for opioid dependence. Subst Use Misuse 2005;40:1765-1776.
19. Chen CY, Storr CL: Alcohol use and health-related quality of life among youth in Taiwan. J Adolesc Health 2006;39:752e9-e16.
20. Daeppen JB, Krieg MA, Burnand B, Yersin B: MOS-SF-36 in evaluating health-related quality of life in alcohol-dependent patients. Am J Drug Alcohol Abuse 1998;24:685-694.
21. de Millas W, Lambert M, Naber D : The impact of subjective well-being under neuroleptic treatment on compliance and remission. Dialogues Clin Neurosci 2006;8:131-136.
22. Torrens M, San L, Martinez A, Castillo C, Domingo-Salvany A, Alonso J: Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 1997;92:707-716.
23. Giacomuzzi SM, Riemer Y, Ertl M, Richter R, Rössler H, Hinterhuber H, Kurz M: Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment. Addiction 2003;98:693-702.
24. Giacomuzzi SM, Riemer Y, Kemmler G, Ertl M, Richter R, Rössler H, Hinterhuber H: Substitutionsbehandlung und Lebensqualität: Methadon vs. retardiertes Morphin-Sulfat - eine Vergleichsstudie. Suchtmed 2001;3:89-95.
25. Bullinger M: Quality of life: definition, conceptualisation and implications: a methodologist's view. Theor Surg 1991;6:143-148.
26. Vanagas G, Padaiga Z, Subata E: Economic efficiency of methadone maintenance and factors affecting it. Medicina (Kannas) 2004;40:607-613.
27. Sees KL, Delucchi KL, Masson C, Rosen A, Clark HW, Robillard H, Banys P, Hall SM: A randomized, controlled trial of methadone maintenance versus 180-day psychosocially-enriched detoxification: drug use, HIV-risk and psychosocial functioning. JAMA 2000;283:1303-1310.
28. Eder H, Jagsch R, Kraigher D, Primorac A, Ebner N, Fischer G: Comparative study of the effectiveness of slow-release morphine and methadone for opioid maintenance therapy. Addiction 2005;100:1101-1109.
29. Maxwell S, Shinderman MS: Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone. J Addict Dis 2002;21:1-12.
30. Mitchell TB, White JM, Somogyi AA, Bochner F: Switching between methadone and morphine for maintenance treatment of opioid dependence: impact on pain sensitivity and mood status. Am J Addict 2006;15:311-315.
31. Mitchell TB, White JM, Somogyi AA, Bochner F: Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence. Addiction 2004;99:940-945.
32. Kraigher D, Ortner R, Eder H, Schindler S, Fischer G: Slow-release morphine hydrochloride for maintenance therapy of opioid dependence. Wien Klin Wochenschr 2002;114:904-910.
33. Giacomuzzi S, Kemmler G, Ertl M, Riemer Y: Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants. Subst Use Misuse 2006;41:223-244.
34. Habrat B, Chmielewska K, Baran-Furga H, Keszycka B, Taracha E: Subjective quality of life in opiate-dependent patients before admission after six months and one-year participation in methadone program. Przegl Lek 2002;59:351-354.
35. Fischer G, Eder H, Peternell A, Windhaber J: Lebensqualität gravider substanzabhängiger Frauen unter oraler Erhaltungstherapie mit synthetischen Opioiden. Nervenheilkunde 2000;19:205-211.
36. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) . Washington, DC, American Psychiatric Association, 1994.
37. Gsellhofer B, Küfner H, Vogt M, Weiler D: European Addiction Index: manual für Training und Durchführung. Battmannsweiler, Schneider, 1999.
38. Priebe S, Gruyters T, Heinze M, Hoffmann C, Jäkel A: Subjektive Evaluationskriterien in der psychiatrischen Versorgung - Erhebungsmethoden für Forschung und Praxis. Psychiatr Prax 1995;22:140-144.
39. Lehmann AF: The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Eval Program Plann 1983;6:143-151.
40. Van Nieuwenhuizen C, Schene AH, Koeter MW, Huxley P: The Lancashire Quality of Life Profile: modification and psychometric evaluation. Soc Psychiatry Psychiatr Epidemiol 2001;36:36-44.
41. Ritsner M, Modai I, Kurs R, Kostizky H, Ponizovsky A: A comparison between the Hebrew versions of the Quality of Life Enjoyment and Satisfaction Questionnaire and the Lancashire Quality of Life Profile in severely mentally ill patients. QoL Newslett 2001;26:12-13.
42. Eack S, Newill C: Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull 2007;33:1225-1237.
43. Vasilev GN, Alexieva DZ, Pavlova RZ: Safety and efficacy of oral slow release morphine for maintenance treatment on heroin addicts: a 6-month open noncomparative study. Eur Addict Res 2006;12:53-60.
44. Torrens M, Domingo-Salvany A, Alonso J, Castillo C, San L: Methadone and quality of life. Lancet 1999;353:1101.
45. Huppert JD, Weiss KA, Lim R, Pratt S, Smith TE: Quality of life in schizophrenia: contributions of anxiety and depression. Schizophr Res 2001;51:171-180.
46. Van den Brink W, Haasen C: Evidence-based treatment of opioid-dependent patients. Can J Psychiatry 2006;51:635-646.